NSE: GUJTERC | BSE: 524314 | ISIN: INE499G01013

INDUSTRY : Pharmaceuticals

Gujarat Terce Laboratories Ltd.

6.71 0.08(1.21%)

31.67% Fall from 52W High

Volume: 100

BSEFeb 17, 2020 15:35

Check Buy or Sell



6.71
1.21%
6.71
1.21%
6.71
1.21%
6.71
1.21%
default
6.71
1.21%
Gujarat Terce Laboratories Ltd - 524314 - Intimation Of Disposal Of Partner'S Contribution In Terce Wellness ...
BSE India
With reference to the captioned subject, we wish to inform that Board of Directors in its Board Meeting held on 13th February, 2020 have decided to dispose the Company's contribution of Rs. 50,000/- held in Terce Wellness LLP. Thus there will be no holding of Gujarat Terce Laboratories Limited in Terce Wellness LLP and the said LLP ceases to be the Associate LLP of the Company.
default
6.71
1.21%
Gujarat Terce Laboratories Ltd - 524314 - Appointment of Company Secretary and Compliance Officer
BSE India
Pursuant to the provisions of Regulation 30 and Regulation 6 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, Please note that Ms. Ashka Solanki (ACS: A56817) has been appointed for the post of Company Secretary and Compliance officer of the Company w.e.f 13th February, 2020 and her appointment has been confirmed in duly held Board Meeting dated 13th February, 2020.
6.71
1.21%
Gujarat Terce Laboratories Ltd - 524314 - Result For The Quarter Ended 31.12.2019
BSE India
Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., on Thursday, 13th February, 2020 which commenced at 3:00 p.m. and concluded at 4:00 p.m. inter alia, have approved the following
6.71
1.21%
Gujarat Terce Laboratories Ltd - 524314 - Outcome Of Board Meeting Held On 13Th February, 2020.
BSE India
Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., on Thursday, 13th February, 2020 which commenced at 3:00 p.m. and concluded at 4:00 p.m. inter alia, have approved the following
6.71
1.21%
Gujarat Terce Laboratories Ltd - 524314 - Outcome Of Board Meeting Held On 13Th February, 2020.
BSE India
Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Schedule III to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., on Thursday, 13th February, 2020 which commenced at 3:00 p.m. and concluded at 4:00 p.m. inter alia, have approved the following
6.71
1.21%
GUJARAT TERCE LABORATORIES LTD. - 524314 - Board Meeting Intimation for Intimation Of The Board Meeting ...
BSE India
GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve With reference to the captioned subject, please take note that the Meeting of Board of Directors of the Company schedule to be held on Thursday, 13th February, 2020 at D-802, The First, B/h. Keshavbaug Party Plot, Near Shivalik High-Street, Vastrapur, Ahmedabad -380015 Gujarat at 3.00 p.m. regarding the following matters: 1. To consider and approve the Unaudited Financial Results for the quarter and Nine months ended on 31st December, 2019. 2. To re-constitute Audit committee, Stakeholder Relationship Committee and Nomination & Remuneration Committee. 3. To appoint Ms. Ashka Solanki, as the Company Secretary cum Compliance Officer of the Company. 4. To consider any other matter with the permission of the Chair. This is in compliance with Regulation 29 and other relevant regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Month Change by -21.8% (Crossed threshold 20%) on 11 February, 2020
  • Stock Price (7.32) crossed below 100 Day SMA (7.6) on 06 February, 2020
  • Stock Price (7.7) crossed below 150 Day SMA (7.83) on 05 February, 2020
  • Stock Price (7.96) crossed below 200 Day SMA (8.28) on 29 January, 2020
  • Stock Price (8.36) crossed below 30 Day SMA (8.66) on 28 January, 2020
More triggered alerts